Clene Inc. SEC filings CLNN

Clene Inc. has 707 filings in SEC EDGAR's recent list, going back to Sep 10, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Clene Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Apr 10, 2026 —
DEF 14A Proxy statement Apr 10, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 8, 2025 —
DEF 14A Proxy statement Apr 8, 2025 Dec 31, 2024
PRE 14A Preliminary proxy statement Mar 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 16, 2024 —
DEF 14A Proxy statement Apr 16, 2024 Dec 31, 2023
PRE 14A Preliminary proxy statement Apr 5, 2024 Dec 31, 2023
DEFA14A Additional proxy material Mar 28, 2023 —
DEF 14A Proxy statement Mar 28, 2023 Dec 31, 2022
PRE 14A Preliminary proxy statement Mar 17, 2023 Dec 31, 2022
DEFA14A Additional proxy material Mar 29, 2022 —
DEF 14A Proxy statement Mar 24, 2022 Mar 24, 2022
DEFA14A Additional proxy material Apr 9, 2021 —
DEF 14A Proxy statement Apr 5, 2021 May 18, 2021
PRE 14A Preliminary proxy statement Mar 18, 2021 Mar 18, 2021

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CLNN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Salt Lake City, UT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1822791
Former names
Chelsea Worldwide Inc. (until Dec 18, 2020)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.